Drug-drug Interaction Study with AZD5305 and Itraconazole in Patients with Advanced Solid Malignancies

Trial Identifier:	D9720C00005
Sponsor:	AstraZeneca
NCTID::	NCT05573724
Start Date:	November 2022
Primary Completion Date:	July 2023
Study Completion Date:	July 2023
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GE	Tbilisi, GE, 112
MD	Chisinau, MD, MD-2025
RO	Cluj-Napoca, RO, 400015

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.